Achieved record gross bookings of $65.8 million and revenue of $59.7 million in full-year 2024Signed 46 new customers in 2024 and expanded ...

Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and ...

Financial Guidance: Celldex believes that the cash, cash equivalents and marketable securities at December 31, 2024 are sufficient to meet estimated working capital requirements and fund current ...

3. Dependent on you. Your loved one lives with you for more than half a year, and you pay more than 50 percent of that person’s living expenses, including clothing, food, lodging, medical and dental ...

An expense ratio is a measure of how much it ... But investing in these "load funds" is completely avoidable -- be wary of financial professionals who try to sell you shares in load funds ...

Neuroscience Pipeline Highlights Vistagen is also continuing: Financial Results for Fiscal Year 2025 Third Quarter Ended December 31, 2024 Research and development (R&D) expense General and ...

Full details of our financial and operating results may be found within our 2024 Annual Financial Review, which is available on the Corporation's issuer profile on SEDAR+ at www.sedarplus.ca or on ...

We repeat this statement ... certain financial measures that are not prepared in accordance with GAAP, including adjusted cost of revenue, adjusted sales and marketing expense, adjusted research ...

today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided a corporate update. "We made significant progress across our pipeline in 2024 ...